Inventor · disambiguated record
Jung Yeon Lim
Also filed as: LIM JUNG YEON
9 granted patents·5 pending applications·0 citations·filing 2009–2024
74Inventor score
Files withCATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION7CATHOLIC UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION4LG CHEMICAL LTD1SK HYNIX INC1WHANG SUNG-JIN1
Top patents by PatentIndex Score
14 records- 0168US12427230B2Human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted construct, and use thereofCATHOLIC UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION·Filed 2024·Granted Sep 30, 2025·0 cites·4 claims
- 0261US2024329057A1Detection of Beta Amyloid Protein as Alzheimer's Disease-Causing Factor in Palatine Tonsil and Use ThereofCATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION·Filed 2023·Application pending·0 cites
- 0356US9293337B2Semiconductor device and method for fabricating the sameSK HYNIX INC·Filed 2014·Granted Mar 22, 2016·0 cites·7 claims
- 0456US8847300B2Semiconductor device and method for fabricating the sameWHANG SUNG-JIN·Filed 2009·Granted Sep 30, 2014·0 cites·14 claims
- 0555US2023265435A1Composition comprising osteopontin inhibitor as active ingredient for prevention, alleviation, or treatment of neurodegenerative diseaseCATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION·Filed 2021·Application pending·0 cites
- 0654US2023405051A1Pharmaceutical composition for prevention or treatment of rheumatoid arthritis, comprising, as active ingredient, stem cells having expression of specific genes increased or decreased thereinCATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION·Filed 2021·Application pending·0 cites
- 0753US2024238343A1Pharmaceutical composition for preventing or treating brain and nervous system diseasesCATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION·Filed 2021·Application pending·0 cites
- 0847US11612620B2Pharmaceutical composition for preventing or treating rheumatoid arthritis comprising nasal inferior turbinate-derived mesenchymal stem cells as an active ingredientCATHOLIC UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION·Filed 2018·Granted Mar 28, 2023·0 cites·8 claims
- 0947US10792309B2Cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory t-cells as active ingredientCATHOLIC UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION·Filed 2013·Granted Oct 6, 2020·0 cites·4 claims
- 1047US2021196760A1Pharmaceutical composition for treating cartilage damage, comprising nasal septum chondrocytesCATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION·Filed 2019·Application pending·0 cites
- 1146US11938247B2Human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted construct, and use thereofCATHOLIC UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION·Filed 2018·Granted Mar 26, 2024·0 cites·3 claims
- 1244US9867832B2Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cellsLG CHEMICAL LTD·Filed 2014·Granted Jan 16, 2018·0 cites·10 claims
- 1339US11473059B2Method for enrichment and expansion of virus antigen-specific T cellsCATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION·Filed 2016·Granted Oct 18, 2022·0 cites·7 claims
- 1436US10272092B2Composition for preventing or treating mucositis comprising NecroX as effective ingredientCATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION·Filed 2015·Granted Apr 30, 2019·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Jung Yeon Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →